O-P]DDD THERAPY IN CUSHINGS SYNDROME + IN OBESITY WITH CUSHINGOID CHANGES

[1] ALBERT A, 1956, RECENT PROG HORM RES, V12, P227

[2] BAGSHAWE KD, 1960, LANCET, V2, P284

[3] CHEMOTHERAPY OF ADRENOCORTICAL CANCER WITH O,P'DDD [J]. ANNALS OF INTERNAL MEDICINE, 1960, 53 (04) : 672 - 682

[4] BERGENSTAL DM, 1959, T ASSOC AM PHYSICIAN, V72, P341

[5] BLEDSOE T, 1963, 45 M END SOC ATL CIT

[6] CROWLEY LV, 1962, CLIN RES, V10, P85

[7] BIOLOGICAL STUDIES ON AN ADRENOCORTICOLYTIC AGENT AND THE ISOLATION OF THE ACTIVE COMPONENTS [J]. ENDOCRINOLOGY, 1958, 62 (03) : 334 - 339

[8] CHEMICAL FRACTIONATION OF AN ADRENOCORTICOLYTIC DRUG [J]. ENDOCRINOLOGY, 1958, 62 (03) : 326 - 333

[9] THYROIDITIS FOLLOWING ADMINISTRATION OF THYROID-STIMULATING HORMONE [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1960, 20 (11) : 1521 - 1525

[10] DANOWSKI TS, 1962, METABOLISM, V11, P689

[1] ALBERT A, 1956, RECENT PROG HORM RES, V12, P227

[2] BAGSHAWE KD, 1960, LANCET, V2, P284

[3] CHEMOTHERAPY OF ADRENOCORTICAL CANCER WITH O,P'DDD [J]. ANNALS OF INTERNAL MEDICINE, 1960, 53 (04) : 672 - 682

[4] BERGENSTAL DM, 1959, T ASSOC AM PHYSICIAN, V72, P341

[5] BLEDSOE T, 1963, 45 M END SOC ATL CIT

[6] CROWLEY LV, 1962, CLIN RES, V10, P85

[7] BIOLOGICAL STUDIES ON AN ADRENOCORTICOLYTIC AGENT AND THE ISOLATION OF THE ACTIVE COMPONENTS [J]. ENDOCRINOLOGY, 1958, 62 (03) : 334 - 339

[8] CHEMICAL FRACTIONATION OF AN ADRENOCORTICOLYTIC DRUG [J]. ENDOCRINOLOGY, 1958, 62 (03) : 326 - 333

[9] THYROIDITIS FOLLOWING ADMINISTRATION OF THYROID-STIMULATING HORMONE [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1960, 20 (11) : 1521 - 1525

[10] DANOWSKI TS, 1962, METABOLISM, V11, P689